34
Participants
Start Date
October 31, 2009
Primary Completion Date
July 31, 2013
Study Completion Date
April 30, 2015
Bendamustine
90 mg/m2/day IV days 1 and 2 every 28 days for 6 cycles
Rituximab
375 mg/m2 Day 1 every 28 days for 6 cycles
Lenalidomide
5 mg/day days 1-28 of each 28 day cycle, up to 12 cycles maximum. Dose escalation to 10 mg/day allowed after one cycle as defined in the protocol.
Oconomowoc Memorial Hospital, Oconomowoc
Waukesha Memorial Hospital, Waukesha
Medical College of Wisconsin, Milwaukee
Mercy Health System Heme/Onc, Janesville
University of Wisconsin Carbone Cancer Center, Madison
St Vincent Regional Cancer Center, Green Bay
Bellin Memorial Hospital, Green Bay
Marshfield Clinic, Marshfield
Riverview Hospital, Wisconsin Rapids
Gundersen Clinic, La Crosse
Collaborators (1)
Celgene Corporation
INDUSTRY
University of Wisconsin, Madison
OTHER